المؤلفون: Jack J. Kendall, Charles Ledoux, Francisco C. Marques, Daniele Boaretti, Friederike A. Schulte, Elise F. Morgan, Ralph Müller

المصدر: Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)

مصطلحات موضوعية: computational modelling, agent-based model, bone healing, osteogenesis, angiogenesis, in silico, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fbioe.2023.1289127/full; https://doaj.org/toc/2296-4185

URL الوصول: https://doaj.org/article/c6a1b23257ba485ebb7ffa341c518a2b

المؤلفون: Daniele Boaretti, Francisco C. Marques, Charles Ledoux, Amit Singh, Jack J. Kendall, Esther Wehrle, Gisela A. Kuhn, Yogesh D. Bansod, Friederike A. Schulte, Ralph Müller

المصدر: Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)

مصطلحات موضوعية: micro-FE, bone adaptation, mechanical signal, numerical simulations, bone cells, Biotechnology, TP248.13-248.65

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fbioe.2023.1091294/full; https://doaj.org/toc/2296-4185

URL الوصول: https://doaj.org/article/cab6fc58845449c4a5761a0e04d221de

المؤلفون: Daniele Boaretti, Francisco C. Marques, Charles Ledoux, Amit Singh, Jack J. Kendall, Esther Wehrle, Gisela A. Kuhn, Yogesh D. Bansod, Friederike A. Schulte, Ralph Müller

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::83f531ea331a4e79da94be0a7dec3c49
https://doi.org/10.1101/2022.11.16.516723

المؤلفون: Shah V; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Sherborne AL; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Ellis S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Price A; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Chowdhury F; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Kendall J; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Jenner MW; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Owen RG; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, UK., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, UK., Morgan GJ; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, UK., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Molecular and Population Genetics, The Institute of Cancer Research, London, UK., Jackson G; Department of Haematology, University of Newcastle, Newcastle Upon Tyne, UK., Kaiser MF; Division of Molecular Pathology, The Institute of Cancer Research, London, UK. Martin.Kaiser@icr.ac.uk.

مؤلفون مشاركون: on behalf of NCRI Haematology Clinical Studies Group

المصدر: Leukemia [Leukemia] 2020 Nov; Vol. 34 (11), pp. 3091-3096. Date of Electronic Publication: 2020 Mar 11.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Profiling* , Transcriptome*, Multiple Myeloma/*diagnosis , Multiple Myeloma/*genetics, Biomarkers, Tumor ; Chromosome Aberrations ; Humans ; Multiple Myeloma/mortality ; Multiple Myeloma/therapy ; Prognosis ; Proportional Hazards Models ; Stem Cell Transplantation

المؤلفون: Shah V; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Johnson DC; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Sherborne AL; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Ellis S; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Aldridge FM; Centre for Molecular Pathology, The Royal Marsden Hospital, London, United Kingdom., Howard-Reeves J; Centre for Molecular Pathology, The Royal Marsden Hospital, London, United Kingdom., Begum F; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Price A; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Kendall J; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Chiecchio L; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, United Kingdom., Savola S; MRC-Holland, Amsterdam, Netherlands., Jenner MW; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Owen RG; Haematological Malignancy Diagnostic Service, St. James's University Hospital, Leeds, United Kingdom., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, United Kingdom., Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR., Davies FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR., Houlston RS; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom; and., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, Leeds, United Kingdom., Jackson G; Department of Haematology, University of Newcastle, Newcastle upon Tyne, United Kingdom., Kaiser MF; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.

مؤلفون مشاركون: National Cancer Research Institute Haematology Clinical Studies Group

المصدر: Blood [Blood] 2018 Dec 06; Vol. 132 (23), pp. 2465-2469. Date of Electronic Publication: 2018 Oct 29.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Gene Deletion* , Gene Dosage* , Genomic Instability*, Multiple Myeloma/*genetics , Multiple Myeloma/*mortality , Tumor Suppressor Protein p53/*genetics, Disease-Free Survival ; Female ; Humans ; Male ; Survival Rate

المؤلفون: García-Souto D; Departamento de Bioquímica, Xenética e Inmunoloxía, Universidade de Vigo, E-36310 Vigo, Spain. danielgarciasouto@gmail.com., Pérez-García C; Departamento de Bioquímica, Xenética e Inmunoloxía, Universidade de Vigo, E-36310 Vigo, Spain. concepcionperezgar@gmail.com., Kendall J; Departamento de Bioquímica, Xenética e Inmunoloxía, Universidade de Vigo, E-36310 Vigo, Spain. jk.kendall@hotmail.com., Pasantes JJ; Departamento de Bioquímica, Xenética e Inmunoloxía, Universidade de Vigo, E-36310 Vigo, Spain. pasantes@uvigo.es.

المصدر: Genes [Genes (Basel)] 2016 Aug 16; Vol. 7 (8). Date of Electronic Publication: 2016 Aug 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Print ISSN: 2073-4425 (Print) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: PubMed not MEDLINE